Tilray Brands, Inc. (TLRY) financial statements and ratios from SEC XBRL: revenue $0.9B (TTM), net margin -13.3%, revenue growth 11.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $915.45M |
| Revenue (TTM) | $0.9B |
| Net Margin | -13.3% |
| Operating Margin (TTM) | -6.9% |
| Net Debt / EBITDA | 0.4 |
| Revenue Growth (YoY) | 11.5% |
| EPS Growth (YoY) | -55.7% |
| Price / Book | 0.33 |
| Price / Sales | 0.57 |
| Altman Z-Score | -1.96 (distress) |
| Piotroski F-Score | 3/9 |
| Piotroski checks passed | 3 of 9 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.6 |
TLRY overview · TLRY earnings · TLRY KPIs · TLRY documents · TLRY ownership · TLRY peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.